Nimodipine and acceleration of functional recovery of the facial nerve after crush injury

Archives of Facial Plastic Surgery

Volumn 12, Issue 1, 2010, Pages 49-52

  Lindsay, Robin W ^a   Heaton, James T ^a   Edwards, Colin ^a   Smitson, Christopher ^a   Hadlock, Tessa A ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CONVALESCENCE; DRUG EFFECT; FACIAL NERVE INJURY; FEMALE; RAT; TIME; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; FACIAL NERVE INJURIES; FEMALE; NIMODIPINE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 76749116164     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfacial.2009.95     Document Type: Article

References (29)

1. Yeh C, Bowers O, Hadlock TA. Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch Facial Plast Surg. 2007;9(5):333-339.
2. Ito M, Ohbayashi M, Furukawa M, Okoyama S. Neuroprotective effects of TJ-23 (Tokishakuyakusan) on adult rat motoneurons following peripheral facial nerve axotomy. Otolaryngol Head Neck Surg. 2007;136(2):225-230.
3. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. 2003;17(14):2094-2096.
4. Hindley S, Juurlink BH, Gysbers JW, Middlemiss PJ, Herman MA, Rathbone MP. Nitric oxide donors enhance neurotrophin-induced neurits outgrowth through a cGMP-dependent mechanism. J Neurosci Res. 1997;47(4):427-439.
5. González-Hernández T, Rustioni A. Nitric oxide synthase and growth-associated protein are coexpressed in primary sensory neurons after peripheral injury. J Comp Neurol. 1999:404(1):64-74.
6. Angelov DN, Neiss WF, Streppel M, Andermahr J, Mader K, Stennert E. Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve. J Neurosci. 1996;16(3):1041-1048.
7. Mydman J, Remahl S, Bjorck G, Svensson M, Mattsson P. Nimodipine improves reinnervation and neuromuscular function after Injury to the recurrent laryngeal nerve in the rat. Ann Otol Rhinol Laryngol. 2007;116(8):623-630.
8. Mattsson P, Aldskogius H, Svensson M. Nimodiplne-induced improved survival rate of facial motor neurons following intracranial transection of the facial nerve in the adult rat. J Neurosurg. 1999;90(4):760-765.
9. Mattsson P, Janson AM, Aldskogius H, Svensson M. Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush. J Comp Neurol. 2001;437(1):106-117.
10. Ferri CC, Moore FA, Bisby MA. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol. 1998;34 (1):1-9.
11. Most SP. Facial nerve recovery in bcl2 overexpression mice after crush Injury. Arch Facial Plast Surg. 2004;6(2):82-87.
12. Nichols CM, Myckatyn TM, Rickman SR, Fox IK, Hadlock T, Mackinnon SE. Choosing the correct functional assay: a comprehensive assessment of functional tests in the rat. Behav Brain Res. 2005;163(2):143-158.
13. Hadlock T, Kowaleski J, Lo D, et al. Functional assessments of the rodent facial nerve: a synkinesis model. Laryngoscope. 2008:118(10):1744-1749.
14. Heaton JT, Kowaleski JM, Bermejo R, Zeigler HP, Ahlgren DJ, Hadlock TA. A system for studying facial nerve function in rats through simultaneous bilateral monitoring of eyelid and whisker movements. J Neurosci Methods. 2008:171 (2):197-206.
15. McMonagle-Strucko K, Fanelli RJ. Enhanced acquisition of reversal training in a spatial learning task in rats treated with chronic nimodipine. Pharmacol Biochem Behav. 1993;44(4):827-835.
16. Kusztos RD, Ingram DK, Spangler EL, London ED. Effects of aging and chronic nimodipine on hippocampal binding of [3H]CGS 19755. Neurobiol Aging. 1996; 17(3):453-457.
17. Laslo AM, Eastwood JD, Urquhart B, Lee TY, Freeman D. Subcutaneous administration of nimodipine improves bioavailability in rabbits. J Neurosci Methods. 2004;139(2):195-201.
18. Bridge PM, Ball DJ, Mackinnon SE, et al. Nerve crush injuries: a model for axonotmesis. Exp Neurol. 1994;127(2):284-290.
19. Bermejo R, Vyas A, Zeigler HP. Topography of rodent whisking, I: two-dimensional monitoring of whisker movements. Somatosens Mot Res. 2002;19(4):341-346.
20. Bermejo R, Houben D, Zeigler HP. Optoelectronic monitoring of individual whisker movements in rats. J Neurosci Methods. 1998;83(2):89-96.
21. Gao P, Bermejo R, Zeigler HP. Whisker deafferentation and rodent whisking patterns. J Neurosci. 2001; 21 (14):5374-5380.
22. van der Zee CE, Schuurman T, Traber J, Gispen WH. Oral administration of nimodipine accelerates functional recovery following peripheral nerve damage in the rat. Neurosci Lett. 1987;83(1-2):143-148.
23. Mattsson P, Bjorck G, Remahl S, et al. Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection. Laryngoscope. 2005:115(10):1863-1865.
24. Ingram DK, Joseph JA, Spangler EL, Roberts D, Hengemihle J, Fanelli RJ. Chronic nimodipine treatment in aged rats. Neurobiol Aging. 1994;15(1):55-61.
25. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm. N Engl J Med. 1983; 308(11):619-624.
26. Strauss C, Bischoff B, Neu M, Berg M, Fahlbusch R, Romstock J. Vasoactive treatment for hearing preservation in acoustic neuroma surgery. J Neurosurg. 2001; 95(5):771-777.
27. Strauss C, Bischoff B, Romstock J, Rachinger J, Rampp S, Prell J. Hearing preservation in medial vestibular schwannomas. J Neurosurg. 2008:109(1):70-76.
28. Scheller C, Richter HP, Engelhardt M, Koenig R, Antoniadis G. The influence of prophylactic vasoactive treatment on cochlear and facial nerve functions after vestibular schwannoma surgery: a prospective and open-label randomized pilot study. Neurosurgery. 2007;61(1):92-98.
29. Scheller C, Strauss C, Fahlbusch R, Romstock J. Delayed facial nerve paresis following acoustic neuroma resection and postoperative vasoactive treatment. Zentralbl Neurocchir. 2004;65(3):103-107.